-- 週三下午晚些時候，醫療保健類股下跌，紐約證券交易所醫療保健指數下跌0.6%，道富醫療保健精選行業SPDR ETF (XLV)下跌0.9%。 iShares生物科技ETF (IBB)下跌1.5%。 在公司新聞方面，波士頓科學公司 (BSX) 股價下跌3.3%，此前大和證券將該股評級從“跑贏大盤”下調至“中性”，並將目標股價從之前的每股83美元下調至60美元。 艾伯維 (ABBV) 週三上調了全年業績預期，這家生物製藥公司公佈的第一季業績好於預期，主要得益於其Skyrizi和Rinvoq免疫藥物的強勁營收成長。該公司股價上漲3.7%。 根據彭博社報道，阿斯特捷利康（AZN）將在英國投資3億英鎊（約4.049億美元），重點投資其位於劍橋和麥克爾斯菲爾德的工廠，旨在提振英國生命科學產業。阿斯特捷利康股價下跌1.1%。 卡爾維斯塔製藥（KALV）和凱西集團週三宣布，雙方已簽署協議，凱西將以每股27美元的現金收購卡爾維斯塔，總價約19億美元。卡爾維斯塔股價應聲飆漲38%。
Related Articles
Asia
Super Retail Group Appoints CFO
Super Retail Group (ASX:SUL) appointed Sarah Hunter as chief financial officer, effective June 1, according to a Thursday filing with the Australian bourse.Hunter will succeed David Burns, who will remain CFO until Aug. 28 before retiring in November, per the filing.Hunter most recently served as the managing director of Officeworks, the filing added.
$ASX:SUL
Research
Research Alert: Sba Communications Q1: Millicom Integration Drives Growth & Margin Headwinds
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:SBAC reported Q1 revenue of $703M (+5.9% Y/Y), beating consensus estimates by $9M, compared to $664M in Q1 2025. Site leasing revenue rose 6.5% Y/Y to $656M (+4.5% excluding foreign exchange impacts), while site development revenue declined 1.6% to $47M in the quarter. International site leasing revenue surged 32.6% Y/Y (+24.8% ex-FX) to $206M, primarily due to successful Millicom asset integration and expanding Central America build-to-suit tower development activities. Excluding total churn impact, organic leasing revenue growth reached a robust 8.3% Y/Y, with Sprint-related churn at 1.3% and regular churn at 2.7% of revenues. The strong international performance reflects successful integration of recently acquired assets and continued strategic expansion in Central America markets. Overall operational metrics demonstrate solid underlying growth momentum despite ongoing domestic churn headwinds, with international operations providing significant growth acceleration.
$SBAC
Asia
T&G Global Plans Divestment of New Zealand Fresh Produce, Pacific Units
T&G Global (NZE:TGG) said it is in talks to sell its New Zealand fresh produce operations to founder J & P Turner and its Fijian and Pacific businesses to Bidfood to focus on its Apples and VentureFruit platforms, according to a Thursday filing with the New Zealand bourse.The proposed divestments cover T&G Fresh tomato, berry, citrus, and stone fruit growing operations; wholesale networks; and export businesses, per the filing.T&G Global added that it has appointed Goldman Sachs as financial adviser to assess strategic options, including a potential sale of the company, after it was notified of BayWa Global Produce's plan to exit its remaining shareholding.
$NZE:TGG